MediaNewsPublicationsVideosAwareness CampaignsNewsPrintTweet01/16/2023Researchers from the Hospital 12 de Octubre and the Josep Carreras Institute create a cell therapy based on STAb cells for a type of leukemia with few treatment optionsMore01/11/2023Pathway identified for overcoming treatment resistance in a particular type of leukemiaMore12/21/2022World's first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorisedMore08/01/2022Leukaemia vulnerability discovered causing drug sensitivityMore06/10/2022A mechanism is found explaining how cancer cells turn into normal harmless onesMore05/11/2022A refined bioinformatic analysis can estimate gene copy-number variations from epigenetic dataMore05/06/2022The Josep Carreras Leukaemia Research Institute, has been selected by the National Cancer Institute for the Cancer Proteome Project with the support of the Spanish Ministry of Science and InnovationMore04/21/2022Predicting response to adoptive cell therapies in cancerMore04/19/2022The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first timeMore04/01/2022Study sheds light on why immunodeficiency affects only one identical twinMore12345678910NextLastWebpage updated 10/16/2019 13:23:15
01/16/2023Researchers from the Hospital 12 de Octubre and the Josep Carreras Institute create a cell therapy based on STAb cells for a type of leukemia with few treatment optionsMore
01/11/2023Pathway identified for overcoming treatment resistance in a particular type of leukemiaMore
12/21/2022World's first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorisedMore
05/11/2022A refined bioinformatic analysis can estimate gene copy-number variations from epigenetic dataMore
05/06/2022The Josep Carreras Leukaemia Research Institute, has been selected by the National Cancer Institute for the Cancer Proteome Project with the support of the Spanish Ministry of Science and InnovationMore
04/19/2022The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first timeMore
José Carreras Leukaemia Foundation